Personal Care Products

Biohigh

Biohigh released FY2026 Q1 earnings on April 15 After-Market (BJT), actual revenue CNY 251.97 M, actual EPS CNY 0.46

Biohigh released FY2025 Q4 earnings on April 15 After-Market (BJT), actual revenue CNY 265.58 M, actual EPS CNY 0.47

Biohigh released FY2025 Annual Earnings on April 15 After-Market (BJT), Actual Revenue: CNY 910.93 M, Actual EPS: CNY 2.05

Biohigh to Release FY2026 Q1 Earnings on April 16 After-Market (BJT)

Biohigh to Release FY2025 Earnings on April 16 After-Market (BJT)

Biohigh released FY2025 Q3 earnings on October 29 During-Market (BJT), actual revenue CNY 225 M, actual EPS CNY 0.4548

Biohigh released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 645.35 M, actual EPS CNY 1.5747

Biohigh to Release FY2025 Q3 Earnings on October 30 During-Market (BJT)

Biohigh released FY2025 Semi-Annual earnings on August 29 After-Market (BJT), actual revenue CNY 420.35M, actual EPS CNY 1.12

Biohigh released FY2025 Q2 earnings on August 29 After-Market (BJT), actual revenue CNY 213.33 M, actual EPS CNY 0.5699

Biohigh to Release FY2025 Semi-Annual Earnings on August 30, 2025 (BJT)

Wang Wentong Sells 424,000 Shares of Baihe Co.

Eastwu Securities Rates Baihe Shares as Buy

Weihai Baihe Bio Suspected of Commercial Kickbacks

Eastwu Securities Issues Buy Rating Report on Baihe Co.

Plan for Director of Baihe Shares to Reduce Shares

Eastwu Securities Gives Buy Rating to Baihe Holdings

Eastwu Securities Publishes Buy Rating Report on Baihe Shares

Baihe Co. Received Buy Rating from Dongwu Securities

Biohigh released FY2024 Annual Earnings on April 14, 2025 (BJT) with actual revenue of CNY 801.4 M and EPS of CNY 2.18

The global stigmasterol-rich plant sterols market is projected to reach USD 1,281.42 million by 2036, driven by rising cardiovascular health awareness and demand for functional foods. The market is transitioning towards standardized formulations and regulatory support, with significant growth in applications across food, nutraceuticals, and pharmaceuticals. Key growth regions include India, Germany, and China, with a forecast CAGR of 3.8% from 2026 to 2036. The market is bolstered by increasing consumer preference for plant-based wellness solutions and regulatory approvals for health claims.

MorningStar

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

603102

300791

Huachuang Securities released a research report indicating that China's functional food industry has maintained a compound annual growth rate of 6.3% over the past five years, significantly higher than other consumer goods categories. Economic stability, aging population, and the rise of Generation Z are driving the accelerated penetration of functional foods, with consumer groups including women, teenagers, infants, and pets. Online channels such as Douyin and cross-border e-commerce are experiencing rapid growth, and the industry landscape shows a coexistence of leading companies and long-tail players. It is recommended to pay attention to companies like SIRIO and Biohigh

Zhitong

SIRIO

HuaChuang Securities: Functional foods accelerate penetration, tapping into new opportunities in industry reshaping

Biohigh announced that its operating revenue in the first half of 2025 is 420 million yuan, a year-on-year increase of 2.06%. The net profit is 71.8783 million yuan, a year-on-year decrease of 13.37%

Biohigh: Net profit of 71.8783 million yuan in the first half of 2025, a year-on-year decrease of 13.37%

001339

688283

On Friday, 9 companies had their restricted shares unlocked, with a total unlock volume of 158 million shares and an unlock market value of 5.146 billion yuan. JWIPC, KSW-TECH, and Rongfa Nuclear Power had the highest unlock volumes, at 44 million shares, 36.3084 million shares, and 32.1003 million shares, respectively. In terms of unlock market value, JWIPC, Biohigh, and KSW-TECH were 2.371 billion yuan, 1.193 billion yuan, and 1.054 billion yuan, respectively. Companies with an unlock ratio exceeding 10% include Biohigh, KSW-TECH, and JWIPC, with ratios of 43.96%, 29.81%, and 17.47%, respectively

JWIPC

KSW-TECH

Overview of A-share restricted stock unlocks | Restricted stocks worth 5.146 billion yuan are unlocked today

Biohigh announced that the company's director, Wang Wentong, reduced his holdings by a total of 424,000 shares through centralized bidding from June 13, 2025, to July 16, 2025, accounting for 0.6625% of the company's total share capital. The reduction price range was between 44.42 and 45.55 yuan/share, with a total reduction amount of 19.1454 million yuan. After the completion of this reduction plan, Mr. Wang Wentong currently holds 1.2735 million shares, with a shareholding ratio reduced to 1.99%. The actual reduction situation is consistent with the previously disclosed reduction plan

Biohigh: Director Wang Wentong reduces holdings by 424,000 shares

According to the Zhitong Finance APP, Biohigh announced that director Wang Wentong plans to reduce his holdings in the company by no more than 424,000 shares, accounting for no more than 0.6625% of the company's total share capital. This reduction plan will be carried out within three months after the announcement date, starting fifteen trading days later (no reduction during the window period)

Biohigh director Wang Wentong plans to reduce holdings by no more than 424,000 shares

Biohigh released its 2024 annual performance, with operating revenue of 801 million yuan, a year-on-year decrease of 8.02%; net profit attributable to the parent company of 139 million yuan, a year-on-year decrease of 17.6%; net profit excluding non-recurring gains and losses of 131 million yuan, a year-on-year decrease of 19.26%; basic earnings per share of 2.18 yuan/share. The company plans to distribute a cash dividend of 7.50 yuan (including tax) for every 10 shares

Biohigh released its 2024 annual performance, with a net profit attributable to the parent company of 139 million yuan, a year-on-year decrease of 17.6%

Biohigh released its Q1 2025 performance report, with operating revenue of 207 million yuan, a year-on-year increase of 9.75%; net profit attributable to the parent company of 35.2058 million yuan, a year-on-year increase of 1.02%; net profit after deducting non-recurring gains and losses of 35.0087 million yuan, a year-on-year increase of 0.80%; basic earnings per share of 0.55 yuan/share

Biohigh released its first-quarter performance, with a net profit attributable to the parent company of 35.2058 million yuan, a year-on-year increase of 1.02%

Biohigh(603102.SH)